India’s Pharma Pivots Beyond US: The Trump Effect Gamble Delivers Results
Indian pharmaceutical companies have executed one of the most strategic pivots in recent corporate history. For decades, the United States represented the golden goose—the largest export destination where Indian generics manufacturers built empires on affordable medicines. Then came the Trump administration’s unpredictable trade rhetoric and regulatory pressures, sending alarm bells ringing across boardrooms in Mumbai […]
India’s Pharma Pivots Beyond US: The Trump Effect Gamble Delivers Results Read More »









